Precision therapeutic approaches for rare neurological diseases are often hampered by a limited molecular understanding of the disease. Here, we report the first application of spatially-resolved proteomics to guide targeted treatment in a monogenic leukoencephalopathy. We investigated leukoencephalopathy with calcific...
Nils Briel, A. Köpp, Hanna Meister et al.· Brain : a journal of neurolo...· 0 citations
Inducing antigen-specific immune tolerance is a long-standing aim in organ-specific autoimmune diseases including multiple sclerosis (MS). We developed a therapy based on autologous red blood cells (RBCs) as tolerizing carriers of autoantigens and tested these in an open-label, dose-escalation, phase Ib clinical trial...
Andreas Lutterotti, Thomas Ludersdorfer, M. Docampo et al.· Proceedings of the National...· 1 citation
Amyloid PET demonstrates high sensitivity and specificity for CA detection, even though the evidence base remains limited in terms of the number and scope of available studies.
A. Walser, K. Bitos, Andreas A. Giannopoulos et al.· European heart journal. Imag...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.